SPEAKERS
Dr. Komrokji is the Vice chair of the Malignant Hematology Department at the Moffitt Cancer Center, Tampa, Florida.
He is a senior Member of the Malignant Hematology and Experimental Therapeutics Program at the Moffitt Cancer Center, and Professor in Medicine & Oncologic Sciences at the College of Medicine, at the University of South Florida in Tampa, Florida.
After earning a medical degree in 1996 from the Jordan University School of Medicine, Dr. Komrokji completed an internship and residency at Case Western University, St. Vincent Program. He then completed a fellowship at Strong Memorial Hospital, University of Rochester, in Hematology/Oncology and Hematopoietic Stem Cell Transplantation.
Dr. Siddiqui is an Assistant Professor in Genitourinary Medical Oncology at the University of Texas
MD Anderson. He is a clinical and translational investigator with a focus on:1) biomarker-rich trials
of novel immunotherapy strategies in prostate cancer, with a special emphasis on T cell engagers;
and 2) improving outcomes in immune-mediated toxicities through identification of mechanistic
biomarkers for early detection and rational intervention.
Alex A. Adjei, MD, PhD, FACP, FASCO, is the Chief of the Cleveland Clinic Cancer Institute, overseeing cancer programs across Cleveland Clinic locations in Ohio, Florida, Abu Dhabi, and London. He is also the Director of the Taussig Cancer Center and holds a distinguished chair in Translational Cancer Research. Dr. Adjei has served on several US National Cancer Institute committees and is a member of the NCI Board of Scientific Counselors. He is editor-in-chief of the Journal of Thoracic Oncology and President-Elect of the International Association for the Study of Lung Cancer. His research focuses on experimental therapeutics and clinical drug development, with over 320 publications to his name.
Kerry S. Courneya, Ph.D., is a Professor in the Faculty of Kinesiology, Sport, and Recreation at the University of Alberta in Edmonton, Canada. His research program focuses on the role of exercise after a cancer diagnosis including how exercise might help cancer patients prepare for treatments, tolerate and respond to treatments, recover after treatments, and improve long-term outcomes. He has published over 600 peer reviewed scientific papers including many influential randomized controlled trials in colon, breast, prostate, lymphoma, and testicular cancer patients. He is study co-chair for the CHALLENGE trial which is the first phase 3 trial demonstrating a cancer-related survival benefit from a structured exercise program. In 2023, Prof. Courneya was appointed an Officer in the Order of Canada for his scientific contributions to the field of exercise oncology.
Ishwaria Subbiah, MD, MS, FASCO, is a palliative care & integrative medicine physician and medical oncologist based in Nashville, TN. With over 16 years of progressive responsibilities in care delivery and access optimization across academic centers, research institutes, and community practice networks, Dr. Subbiah hold an extensive expertise in navigating complex health systems to implement enterprise-level programs.
Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford University School of Medicine. He currently serves as the Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute (SCCI).
Dr. Arturo Loaiza-Bonilla, MD, MSEd, is the Systemwide Chief of Hematology and Oncology at St. Luke’s University Health Network, leading a dynamic oncology team spanning 15 hospitals across 11 counties in Pennsylvania and New Jersey, all part of a nationally recognized healthcare system.
Rolfo will serve as a professor in The Ohio State University College of Medicine, Department of Internal Medicine, and as associate director for early phase clinical trials in Ohio State’s Comprehensive Cancer Center. He will oversee more than 65 faculty who provide subspecialized care and/or conduct research for breast, endocrine, gastrointestinal, genitourinary, lung, skin and head and neck cancers as well as sarcoma.
Daniel Flora, MD
St. Elizabeth
Jennifer L. Leddon, MD, PhD
University of Cincinnati
Muhammad Riaz, MD
St. Elizabeth
Robert L. Cody, MD
Robert L. Cody, MD
Alexander Starodub, MD
The Christ Hospital
Seerin Viviane Shatavi, MD
TriHealth
Olugbenga Olowokure, MD
University of Cincinnati
Minsig Choi, MD
St. Elizabeth
James H. Essell, MD
Oncology Hematology Care
Philip D. Leming, MD
Cincinnati Cancer Advisors
Lauren Mendelson, DO
University of Cincinnati
Jayadev Mettu, MD
Oncology Hematology Care
Tahir Latif, MBBS, MBA
University of Cincinnati
Mufti Naeem Ahmad, MD
TriHealth